Product Name | ALWDVALLEV |
Product Quantity | 4mg |
Catalog Number | LT8262 |
Category | CMV_US150A |
Sequence | ALWDVALLEV is an 11-amino acid peptide derived from the US150A protein of Human Cytomegalovirus (HCMV). |
Purity | >95% |
Product Description | This peptide is implicated in modulating host immune responses during HCMV infection. While specific data on the ALWDVALLEV epitope are scarce, peptides from US150A are used in research focusing on HCMV's interaction with the immune system, particularly in understanding how the virus evades immune detection and establishes latency. The US150A protein of HCMV is involved in modulating host immune responses. Although specific data on the ALWDVALLEV epitope are scarce, peptides from US150A are used in research focusing on HCMV's interaction with the immune system, particularly in understanding how the virus evades immune detection and establishes latency. For researchers interested in studying HCMV's interaction with the immune system, ALWDVALLEV provides a valuable tool for understanding the virus's immune evasion strategies and potential therapeutic targets. |
Scientific Background | ALWDVALLEV is a 10-residue synthetic peptide with the sequence Ala-Leu-Trp-Asp-Val-Ala-Leu-Leu-Glu-Val. The sequence has a relatively high hydrophobic-residue fraction that can influence aqueous solubility and surface adsorption. These sequence-derived properties describe the reagent chemically; no specific receptor, enzyme, pathway, disease association, or biological activity is assigned without product-specific experimental evidence. |
Research Applications | - LC-MS/HPLC analytical method development
- sequence-specific assay controls
|
Experimental Notes | Sequence-derived chemical properties support reagent selection and experimental planning but do not establish biological function. Solubility, aggregation, adsorption, conjugation efficiency, and assay performance should be validated under the intended experimental conditions. |
